Hainan Poly Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SODIUM NITROPRUSSIDE USP, with a corresponding US DMF Number 33023.
Remarkably, this DMF maintains an Active status since its submission on September 06, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 06, 2018, and payment made on September 11, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II